Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04096937 · ClinicalTrials.gov registry record
Journey of Hope in Appalachia: Supporting Resilience in the Region's Youth
A clinical trial of Adverse Childhood Experiences, sponsored by Gia Mudd.
- Completed
- Registry status
- 42
- Enrollment target
- 2
- Study locations
NCT04096937: Completed study of Adverse Childhood Experiences, sponsored by Gia Mudd.
NCT04096937 is a study of Adverse Childhood Experiences that has completed, run by Gia Mudd. The registered enrollment target is 42 participants, below the 327-participant average among 13 other Adverse Childhood Experiences trials with a reported enrollment target (87% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04096937, a study of Adverse Childhood Experiences, has completed, sponsored by Gia Mudd.
- COMPLETED
- Registry status
- 42 participants
- Enrollment target
- 2
- Study locations
Study Summary
Rural youth have heightened exposure to adverse childhood experiences (ACES) such as poverty, social isolation, chronic hunger, and drug use in the home. These threats can lead to downstream problems with emotion regulation, substance abuse, and heightened vulnerability to chronic disease. Resilience is the capacity to adapt positively in the face of such disadvantage. Youth resilience interventions can buffer the negative effects of ACES. Unfortunately, rural schools and other youth-serving agencies often have inadequate capacity to provide such interventions. Thus, there is a critical need to develop cost-effective, sustainable, and culturally-relevant youth resilience interventions that can be delivered by trained personnel with dedicated time and resources. WVU, UK, and Save The Children have a long-term goal to establish a sustained community-engaged research partnership to promote resilience in Appalachian youth. This is a community-based participatory research (CBPR)-guided study being conducted for the purpose of developing a culturally relevant, intervention to promote Appalachian youth resilience. The intervention, called Journey of Hope in Appalachia (JOHA), has as it's starting point Save The Children's evidence-based Journey of Hope (JOH) program that targets youth experiencing acute stress from natural disasters and similar events. This program will be culturally adapted to promote resilience among Appalachian youth experiencing ACES. JOHA will incorporate positive aspects of Appalachian culture (e.g., storytelling, theater, music) and will be designed for sustainability and eventual dissemination by Save through the Appalachian Translational Research Network (ATRN) and other regional Networks.
Primary Outcome
Number of themes that emerge from the focus group data useful for guiding cultural tailoring of the Journey of Hope in Appalachia intervention.
Conditions Studied
Interventions
- OTHER Focus groups
Study Locations (2)
Kentucky
- University of Kentucky, Center of Excellence in Rural Health - Hazard
West Virginia
- West Virginia University - Morgantown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2021-05-01 |
| Est. Completion | 2022-03-22 |
What the finished NCT04096937 record still lists
NCT04096937 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 42 participants, a relatively small participant target, below the 327-participant average among 13 other Adverse Childhood Experiences trials with a reported enrollment target (87% lower).
The record links to 1 condition, with Adverse Childhood Experiences appearing as the primary indexed condition, and to 1 intervention - of which Focus groups is the first listed.
NCT04096937 reports a single indexed study location in Kentucky, West Virginia.
Frequently Asked Questions
What is clinical trial NCT04096937 about?
NCT04096937 is a clinical study titled "Journey of Hope in Appalachia: Supporting Resilience in the Region's Youth". Rural youth have heightened exposure to adverse childhood experiences (ACES) such as poverty, social isolation, chronic hunger, and drug use in the home. These threats can lead to downstream problems with emotion regulation, substance abuse, and heightened vulnerability to chronic disease. Resilienc...
What is the current status of trial NCT04096937?
This trial is currently completed. The enrollment target is 42 participants. The study started on 2021-05-01. Estimated completion is 2022-03-22.
What conditions does trial NCT04096937 study?
This clinical trial studies the following conditions: Adverse Childhood Experiences.
What interventions are being tested in trial NCT04096937?
The interventions under investigation include: Focus groups (OTHER).
Who is sponsoring clinical trial NCT04096937?
This trial is sponsored by Gia Mudd, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04096937 being conducted?
This trial has 2 study locations across Kentucky, West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Adverse Childhood Experiences
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04096937's enrollment target sits among peer trials
42 11th of 13 higher than 3 of 13 other Adverse Childhood Experiences trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Adverse Childhood Experiences trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Life Exposures Among Children With Sickle Cell Disease
RECRUITING · NA
-
The Iowa ACEs and Sleep Cohort and Manipulating Sleep in Young Adults With ACEs Studies
RECRUITING · NA
-
The THRIVE Study: Teaching Healthy Regulation in Individuals & Vulnerable Environments
RECRUITING · NA
-
ACEs, SIRT1, and Premature Vascular Aging in Humans
RECRUITING · NA
-
School Violence Exposure as an Adverse Childhood Experience
RECRUITING
-
Building Resilient Families
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02852213 · 42 participants · Phase 1
A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients
- NCT03136146 · 42 participants · Phase 2
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia
- NCT03178149 · 42 participants · Phase 1
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- NCT03663530 · 42 participants · NA
Circadian Misalignment and Energy Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI